Ness Ziona, Israel

Yossi Dagon

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Aristotle University of Thessaloniki, Hadasit Medical Research Services and Development Ltd.. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yossi Dagon. Retrieved from https://idiyas.com/inventor/yossi-dagon-lrax0r5t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Nes-Ziona, IL (2016)
  • Ness Ziona, IL (2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yossi Dagon - Pioneering Inventor from Ness Ziona, IL

Introduction: Yossi Dagon is a highly accomplished inventor hailing from Ness Ziona, Israel, known for his groundbreaking innovations in various fields.

Latest Patents: Yossi Dagon holds several patents in the areas of technology and healthcare, showcasing his continuous dedication to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Yossi Dagon has worked with leading research institutions and companies, contributing significantly to the development of cutting-edge technologies.

Collaborations: Throughout his career, Yossi Dagon has collaborated with top-notch scientists, engineers, and professionals, fostering a culture of innovation and excellence in all his projects.

Conclusion: Yossi Dagon's relentless pursuit of innovation and his passion for creating solutions to complex problems make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…